The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix

International Journal of Radiation Oncology Biology Physics

Volumn 48, Issue 1, 2000, Pages 201-211

  Nag, Subir ^a   Erickson, Beth ^b   Thomadsen, Bruce ^c   Orton, Colin ^d   Demanes, Jeffrey D ^e   Petereit, Daniel ^c  

^a OHIO STATE UNIVERSITY   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d WAYNE STATE UNIVERSITY   (United States)

^e California Endocurietherapy Cancer Center   (United States)

Author keywords

Brachytherapy; Cervix neoplasm; High dose rate; Interstitial; Intracavitary; Therapy

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN;

ARTICLE; BEAM THERAPY; BRACHYTHERAPY; CANCER STAGING; DOSIMETRY; FOLLOW UP; HUMAN; MEDICAL DOCUMENTATION; PELVIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; RADIATION DOSE; RADIATION FIELD; RADIATION INJURY; SURGICAL TECHNIQUE; SURVIVAL TIME; TREATMENT OUTCOME; TUMOR VOLUME; UTERINE CERVIX CARCINOMA;

ANTINEOPLASTIC AGENTS; BRACHYTHERAPY; CISPLATIN; DOSE FRACTIONATION; FEMALE; HUMANS; NEOPLASM STAGING; QUALITY ASSURANCE, HEALTH CARE; RECTUM; SOCIETIES, MEDICAL; UNITED STATES; URINARY BLADDER; UTERINE CERVICAL NEOPLASMS;

EID: 0034255763     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(00)00497-1     Document Type: Article

References (82)

1. Lanciano R.M., Won M., Coia L.R., et al. Pretreatment and treatment factors associated with improved outcome in squamous cell carcinoma of the uterine cervix A final report of the 1973 and 1978 patterns of care studies . Int J Radiat Oncol Biol Phys. 20:1991;667-676.
2. Montana G.S., Fowler W.C., Varra M.A., et al. Carcinoma of the cervix, stage III Results of radiation therapy . Cancer. 57:1986;148-154.
3. Perez C.A., Breaux S., Madoc-Jones H., et al. Radiation therapy alone in the treatment of carcinoma of the uterine cervix I. Analysis of tumor recurrence . Cancer. 51:1983;1393-1402.
4. Eifel P.J., Morris M., Oswald M.J. The influence of tumor size and growth habit on outcome of patients with FIGO stage IB squamous cell carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys. 27:(1):1993;127-128.
5. Henschke U.K., Hilaris B.S., Mahan G.D. Remote afterloading with intracavitary applicators. Radiology. 83:1964;344-345.
6. O'Connell D., Howard N., Joslin C.A.F., et al. A new remotely controlled unit for the treatment of uterine carcinoma. Lancet. 2:1965;570-571.
7. Wakabayashi M, Irie G, Sugawara T; et al. The trial production of remote after-loading system unit. Japan. Jpn J Clin Radiol 1966;11:678-648.
8. Eifel P.J. High-dose rate brachytherapy for carcinoma of the cervix High tech or high risk . Int J Radiat Oncol Biol Phys. 24:1992;383-386.
9. Stitt J.A., Fowler J.F., Thomadsen B.R., et al. HDR intracavitary brachytherapy for carcinoma of the cervix - the Madison system, I Clinical and radiobiological considerations . Int J Radiat Oncol Biol Phys. 24:1992;335-348.
10. Thomadsen B.R., Shahabi S., Stitt J.A., et al. HDR intracavitary brachytherapy for carcinoma of the cervix - the Madison system, II Procedural and physical considerations . Int J Radiat Oncol Biol Phys. 24:1991;349-357.
11. Akine Y., Tokita N., Ogino T., et al. Dose equivalence for high-dose rate to low-dose rate intracavitary irradiation in the treatment of cancer of the uterine cervix. Int J Radiat Oncol Biol Phys. 19:1990;1511-1514.
12. Arai T., Nakano T., Morita S., et al. High-dose-rate remote afterloading intracavitary radiation therapy for cancer of the uterine cervix. Cancer. 69:1992;175-180.
13. Cikaric S. Radiation therapy of cervical carcinoma using either HDR or LDR afterloading comparison of 5-year results and complications . Strahlenther Onkol. 82:(Suppl.):1988;119-122.
14. Fu K.K., Phillips T.L. High-dose rate vs, low-dose rate intracavitary brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 19:1990;791-796.
15. 192Ir versus conventional radium therapy in cervix cancer 5-year results and complications . Strahlenther Onkol. 82:(Suppl.):1988;106-113.
16. Kuipers T. High dose-rate intracavitary irradiation Results of treatment . Mould R.F. Brachytherapy. 1985;169-175 Nucleotron Trading BV, Leersum, The Netherlands.
17. Orton C.G., Seyedsadr M., Somnay A. Comparison of high and low dose rate remote afterloading for cervix cancer and the importance of fractionation. Int J Radiat Oncol Biol Phys. 21:1991;1425-1434.
18. Patel F.D., Sharma S.C., Negi P.S., et al. Low dose rate vs HDR brachytherapy in the treatment of carcinoma of the uterine cervix A clinical trial . Int J Radiat Oncol Biol Phys. 28:1994;335-341.
19. Sarkaria J.N., Petereit D.G., Stitt J.A., et al. A comparison of the efficacy and complication rates of low-dose rate vs high-dose rate brachytherapy in the treatment of uterine cervical carcinoma. Int J Radiat Oncol Biol Phys. 30:1994;75-82.
20. Shigematsu Y., Nishiyama K., Masaki N., et al. Treatment of carcinoma of the uterine cervix by remotely controlled afterloading intracavitary radiotherapy with HDR A comparative study with a low-dose rate system . Int J Radiat Oncol Biol Phys. 9:1983;351-356.
21. Teshima T., Inoue T., Ikeda H., et al. High-dose rate and low-dose rate intracavitary therapy for carcinoma of the uterine cervix. Cancer. 72:1993;2409-2414.
22. Orton C.G. High and low dose rate brachytherapy for cervical cancer. Acta Oncol. 37:1998;117-125.
23. Petereit D.G., Pearcey R. Literature analysis of high dose rate brachytherapy fractionation schedules in the treatment of cervical cancer Is there an optimal fractionation schedule? Int J Radiat Oncol Biol Phys. 43:1999;359-366.
24. Nag S., Owen J., Farnan N., et al. Survey of brachytherapy practice in the United States A report of the clinical research committee of the American Endocurietherapy Society . Int J Radiat Oncol Biol Phys. 31:1995;103-107.
25. Nag S., Orton C., Young D., et al. American Brachytherapy Society Survey of brachytherapy practice for carcinoma of the cervix in the United States. Gynecol Oncol. 73:1999;111-118.
26. Nag S., Abitbol A.A., Anderson L.L., et al. Consensus guidelines for HDR remote brachytherapy in cervical, endometrial, and endobronchial tumors. Int J Radiat Oncol Biol Phys. 27:1993;1241-1244.
27. Hanks G.E., Kerring D.F., Kramer S. Patterns of care outcome studies. Results of the national practice in cancer of the cervix. Cancer. 51:1983;959-967.
28. Coia L., Won M., Lanciano R., et al. The patterns of care outcome study for cancer of the uterine cervix. Results of the second national practice survey. Cancer. 66:1990;2451-2456.
29. Montana G.S., Hanlon A.L., Brickner T.L., et al. Carcinoma of the cervix Patterns of care studies: Review of 1978, 1983, and 1988-1989 surveys . Int J Radiat Oncol Biol Phys. 32:(5):1995;1481-1486.
30. Montana G.S., Martz K.L., Hanks G.E. Patterns and sites of failure in cervix cancer treated in the USA in 1978. Int J Radiat Oncol Biol Phys. 20:1991;87-93.
31. Corn B.W., Hanlon A.L., Pajak T.F., et al. Technically accurate intracavitary insertions improve pelvic control and survival among patients with locally advanced carcinoma of the uterine cervix. Gynecol Oncol. 53:1994;294-300.
32. Perez C.A., Breaux S., Bedwinek J.M., et al. Radiation therapy alone in the treatment of carcinoma of the uterine cervix II. Analysis of complications. Cancer. 54:1984;235-246.
33. Grinsky T., Rey A., Roche B., et al. Overall treatment time in advanced cervical carcinomas A critical parameter in treatment outcome . Int J Radiat Oncol Biol Phys. 27:1993;1051-1056.
34. Perez C.A., Grigsby P.W., Castro-Vita H., et al. Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy. Int J Radiat Oncol Biol Phys. 32:(5):1995;1275-1288.
35. Petereit D.G., Sarkaria J.N., Hartmann T.J., et al. Adverse effect of treatment prolongation in cervical carcinoma. Int J Radiat Oncol Biol Phys. 32:1995;1301-1307.
36. Lanciano R.M., Pajak T.F., Martz K., et al. The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation A patterns-of-care study . Int J Radiat Oncol Biol Phys. 25:1993;391-397.
37. Eifel P.J., Levenback C., Wharton J.T., et al. Time course and incidence of late complications in patients treated with radiation therapy for FIGO stage IB carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys. 32:1995;1289-1300.
38. Erickson B. Intracavitary applications in the treatment of cancer of the cervix, part 1 Low dose rate techniques . J Brachyther Int. 13:1997;179-205.
39. Morris M., Eifel P., Lu J., et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med. 340:(15):1999;1137-1143.
40. Keys H.M., Bundy B.N., Stehman F.B., et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med. 340:1999;1154-1161.
41. Rose P.G., Bundy B.N., Watkins E.B., et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med. 340:1999;1144-1153.
42. Whitney C.W., Sause W., Bundy B.N., et al. A randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stages IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes. J Clin Oncol. 17:1999;1339-1348.
43. Peters WA III, Liu PY, Barrett R; et al. Cisplatin, 5-fluorouracil plus radiation therapy are superior to radiation therapy as adjunctive in high-risk, early-stage carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: Report of a phase III inter-group study. Presented at the 30th Annual Meeting of the Society of Gynecologic Oncologists; 1999 Mar 20-24; San Francisco.
44. Thomas G.M. Improved treatment for cervical cancer, concurrent chemotherapy and radiotherapy. N Engl J Med. 340:(15):1999;1198-1199.
45. Kavanagh B.D., Bentel G.C., Montana G.S. Soft tissue complication rates after low dose rate brachytherapy using customized perineal templates. Int J Radiat Oncol Biol Phys. 30:1994;508.
46. Clark B.G., Souhami L., Roman T.N., et al. Rectal complications in patients with carcinoma of the cervix treated with concomitant cisplatin and external beam irradiation with high-dose-rate brachytherapy A dosimetric analysis . Int J Radiat Oncol Biol Phys. 28:(5):1994;1243-1250.
47. Clark B.G., Souhami L., Roman T.N., et al. The prediction of late rectal complications in patients treated with high dose-rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 38:1997;989-993.
48. Souhami L., Seymour R., Roman T.N., et al. Weekly cisplatin plus external beam radiotherapy and HDR brachytherapy in patients with locally advanced carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 27:1993;871-878.
49. Erickson B.A. Intracavitary applications in the treatment of cancer of the cervix, part II High dose rate techniques . J Brachyther Int. 13:1997;271-287.
50. Abitbol A.A., Houdek P., Schwade J.G., et al. Ring applicator with rectal retractor Applicability to HDR brachytherapy of cervical cancer . Selectron Brachyther J. 4:1990;68-69.
51. Wollin M., Kagan A.R., Olch A., et al. Comparison of the ring applicator and the Fletcher applicator for HDR gynaecological brachytherapy. Selectron Brachyther J. 2:(Suppl.):1991;25-27.
52. Crook J.M., Esche B.A., Chaplain G., et al. Dose-volume analysis and the prevention of radiation sequelae in cervical cancer. Radiother Oncol. 8:1987;321-332.
53. Smit B.J. HDR brachytherapy for cervical carcinoma using the indwelling intrauterine tube. Selectron Brachyther J. 5:1991;28-32.
54. Smit B.J., du Toit J.P., Groenewald W.A. An indwelling intrauterine tube to facilitate intracavitary radiotherapy of carcinoma of the cervix. Br J Radiol. 62:1989;68-69.
55. Joelsson I., Backstrom A. Dose rate measurements in bladder and rectum intracavitary radiation of carcinoma of the uterine cervix. Acta Radiol. 8:1969;343-359.
56. Tod M., Meredith W. A dosage system for use in the treatment of cancer of the uterine cervix. Br J Radiol. 11:1938;809-824.
57. Tod M., Meredith W. Treatment of cancer of the cervix uteri - a revised "Manchester method." Br J Radiol. 26:1953;252-257.
58. Potish R., Gerbi B., Engler G.P. Dose prescription, dose specification, and applicator geometry in intracavitary therapy. Williamson J.F. Brachytherapy physics. 1995;379-410 Medical Physics Publishing, Madison, WI.
59. ICRU report 38. Dose and volume specification for reporting intracavitary therapy in gynecology. Bethesda, MD: International Commission on Radiation Units and Measurements; 1985. p. 1-20.
60. Schoeppel S.L., LaVigne M.L., Martel M.K., et al. Three-dimensional treatment planning of intracavitary gynecologic implants Analysis of ten cases and implications for dose specification . Int J Radiat Oncol Biol Phys. 28:1994;277-283.
61. Schoeppel S.L., Frass B.A., Hopkins M.P., et al. A CT-compatible version of the Fletcher system intracavitary applicator Clinical application and 3-dimensional treatment planning . Int J Radiat Oncol Biol Phys. 17:1989;1103-1109.
62. AAPM Radiation Therapy Committee Task Group No. 59, Kubo HD, Glasgow GP, Pethel TD; et al. High dose-rate brachytherapy treatment delivery Med Phys 1998;25(4):375-403.
63. Orton CG. Radiobiology. In: Nag S, editor. Principles and practice of brachytherapy. Armonk, NY: Futura Publishing; 1997. p. 27-45.
64. Nag S., Gupta N. A simple method of obtaining equivalent doses for use in HDR brachytherapy. Int J Radiat Oncol Biol Phys. 46:2000;507-513.
65. Ampuero F., Doss L.L., Khan M., et al. The Syed-Neblett interstitial template in locally advanced gynecological malignancies. Int J Radiat Oncol Biol Phys. 9:1983;1897-1903.
66. Aristizabal S.A., Valencia A., Ocampo G., et al. Interstitial parametrial irradiation in cancer of the cervix stage IIB-IIIB Analysis of pelvic control and complications . Endocurie Hypertherm Oncol. 1:1985;41-48.
67. Erickson B., Gillin M.T. Interstitial implantation of gynecological malignancies. Nag S. Principles and practice of brachytherapy. 1997;515-552 Futura Publishing, Armonk, NY.
68. Feder B.H., Syed A.M.N., Neblett D. Treatment of extensive carcinoma of the cervix with the "transperineal parametrial butterfly." Int J Radiat Oncol Biol Phys. 4:1978;735-742.
69. Martinez A., Edmundson G.K., Clarke D. The role of transperineal template implants in gynecological malignancies. Brachyther J. 5:1991;107-113.
70. Syed A.M.N., Puthawala A.A., Neblett D., et al. Transperineal interstitial-intracavitary "syed-neblett" applicator in the treatment of carcinoma of the uterine cervix. Endocuriether Hypertherm Oncol. 2:1986;1-13.
71. Ezzell G.A., Luthmann R.W. Clinical implementation of dwell-time optimization techniques for single stepping-source remote afterloaders. Williamson J.F., Thomadsen B.R., Nath R. Brachytherapy physics. 1995;617-640 Medical Physics Publishing, Madison, WI.
72. Erickson B., Foley W.D., Gillin M., et al. Ultrasound-guided transperineal interstitial implantation of pelvic malignancies Description of the technique . Endocuriether Hypertherm Oncol. 11:1995;107-113.
73. Nag S., Martínez-Monge R., Ellis R., et al. The use of fluoroscopy to guide needle placement in interstitial gynecological brachytherapy. Int J Radiat Oncol Biol Phys. 40:1998;415-420.
74. Demanes D.J., Rodriguez R.R., Hsu I.-C.J., et al. HDR remote afterloading gynaecological template interstitial brachytherapy Rationale, indications and technique. Activity . Intl Nucletron Radiother J. 8:1996;14-21.
75. Erickson B., Albano K., Gillin M. CT-guided interstitial implantation of gynecologic malignancies. Int J Radiat Oncol Biol Phys. 36:1996;699-709.
76. Erickson B., Albano K., Withnell J., et al. Modification of the Syed-Neblett template system to enable loading of the vaginal obturator. Endocuriether Hypertherm Oncol. 12:1996;7-16.
77. Erickson B.A., Erickson S.J., Prost R.W., et al. Magnetic resonance imaging following interstitial implantation of pelvic malignancies. Radiat Oncol Invest. 2:1995;295-300.
78. Demanes J.D., Rodrequez R.R., Bendre D.D., et al. High dose rate transperineal intestitial brachytherapy for cervical cancer High pelvic control and low conplication rates . Int J Radiat Oncol Biol Phys. 45:1999;105-115.
79. Russel A.H., Walter J.P., Anderson M.W., et al. Sagittal magnetic resonance imaging in the design of lateral radiation treatment portals for patients with locally advanced squamous cancer of the cervix. Int J Radiat Oncol Biol Phys. 23:1992;449-455.
80. Kapp K.S., Stuecklschweiger G.F., Kapp D.S., et al. Dosimetry of intracavitary placements for uterine and cervical carcinoma Results of orthogonal film, TLD, and CT assisted techniques . Radiother Oncol. 24:1992;137-146.
81. Stuecklschweiger G.F., Arian-Schad K.S., Poier E., et al. Bladder and rectal dose of gynecologic high-dose rate implants Comparison of orthogonal radiographic measurements with in vivo and CT-assisted measurements . Radiology. 181:1991;889-894.
82. Schoeppel S.L., Ellis J.H., LaVigne M.L., et al. Magnetic resonance imaging during intracavitary gynecologic brachytherapy. Int J Radiat Oncol Biol Phys. 23:1992;169-174.